coisa
-
-
Coya completes enrollment in ALS trial, data due early Q2 2027
-
Shionogi to acquire IntraBio for $2 billion in rare disease push
-
Marea Therapeutics doses first patient in MAR002 phase 2 trial
-
Prime Medicine doses first patient in Wilson disease gene therapy trial
-
Teledyne delivers infrared sensors for U.S. missile defense
-
CAMINUS to manufacture Amprius battery cells in Indianapolis
-
FTC Solar amends credit agreement, defers $5M payment
-
Comtech appoints Christopher Maloney to board of directors
-
Ardelyx to present hyperphosphatemia research at ASN meeting